NJ-based digital health company Curio Digital Therapeutics Inc. announces 510(k) clearance for MamaLift PlusTM, an eight-week prescription digital therapeutic (PDT) for symptomatic treatment for postpartum depression (PPD). Use of MamaLift Plus should...
Advancements help neurologists detect and analyze suspected seizure events from patients in home healthcare settings for extended periods of timeSALT LAKE CITY--(BUSINESS WIRE)--Epitel, a leader in AI technologies for patient-focused brain health solu...
Cardiovascular disease (CVD) affects more than 75 percent of Americans aged 60-79 and more than 90 percent of those aged 80 and over New study shows an overwhelming majority of people aged 65 and over reduced their blood pressure, cholesterol, and...
A new report by the World Health Organization (WHO) provides insights into the digi…
The health innovation community is buzzing with anticipation as the Radical Health …
Call for Proposals Now Open to Digital Health Startups to Compete on the CharmHealth EcosystemPLEASANTON, Calif.--(BUSINESS WIRE)--#AI--CharmHealth, a leader in healthcare technology solutions for providers, today announced the kickoff of its 2024 Inn...
The new capital will accelerate investments in startups with a clear path to elevating health outcomes on a global scaleBOSTON--(BUSINESS WIRE)--SpringTide Ventures, a leader in early-stage HealthTech venture capital, today announced the successful cl...
– Tris Digital Health enters into licensing agreement with Braingaze to develop and commercialize first-in-class, AI-enhanced technology that offers healthcare professionals an objective tool to improve accuracy of ADHD diagnosis – – Tris will conduct...
AI assistants will train healthcare providers on patient assessments and support information collection for diagnosesJACKSON, Wyo.--(BUSINESS WIRE)--Brand Engagement Network (BEN), an emerging provider of personalized customer engagement AI, and OSF H...
Patients age 65+ cite efficiency and preference over traditional paper-based consentingPALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the leading technology provider for modern clinical trials, achieved an impressive 75% adoption of its Total Conse...